Abstract:OBJECTIVE:To investigate the expression of CD19 on childhood acute leukemia (AL) and its significance, and to provide evidence for the diagnosis and differential diagnosis as well as monoclonal antibody-targeting treatment of leukemia.METHODS:There were 210 cases of childhood AL, of which 130 cases were male and 80 were female with a mean age of 9 years old. Using a panel of 27 fluorochrome directly labeled monoclonal antibodies, 210 samples from the patients were analyzed with CD45/SSC double parameters and multi-color flow cytometry to determine the expression of CD19.RESULTS:In the 93 cases of B lineage acute lymphoblastic leukemia (ALL), the positive rate (98.9%, 92/93) of CD19 was significantly higher than that of the other B cell related antigens, such as CD10 (88.2%, 82/93, P = 0.003), CD20 (24.7%, 23/93, P = 0.001) and CD22 (60.2%, 56/93, P = 0.001). CD19 was expressed on all 8 cases of B/myeloid (My) hybrid acute leukemia (HAL) and 1 case of B/T HAL, but was not expressed on all 24 cases of T lineage leukemia and 5 cases of T/My HAL. In the 79 cases of acute myeloid leukemia (AML), only 5 (6.3%) cases expressed CD19. The positive rate (6.3%) of CD19 on AML was significantly lower than that on B lineage ALL (98.9%, P = 0.001). The percentage of CD19 positive cells in B/My HAL (41.6% - 88.7% with a mean of 73.8%) was significant higher than that in CD19(+)-AML (21.4% - 50.4% with a mean of 24.2%; Run Sum test, P = 0.0084). Of the 210 cases, 102 were B lineage related AL including B lineage ALL, B/My HAL and B/T HAL. In B lineage related AL, the sensitivity and the specificity of CD19 was 99.0% (101/102) and 95.4% (13/108) while the positive predictive and the negative predictive values to B lineage were 95.3% (101/106) and 99.0% (103/104), respectively. Using CD19(+) as a single reagent to diagnose B lineage, the false positive rate was 4.6% (5/108) and the false negative rate was 1.0% (1/102) with a general diagnosis index (GDI) of 94.4% [GDI = 1-(false positive rate + false negative rate)].CONCLUSION:CD19 is continuously and stably expressed on all stages of B lineage differentiation. It is a reliable cell membrane marker for diagnosing B lineage ALL and an ideal target for antibody-targeting treatment of leukemia as well; the expression degree of CD19 can be used to distinguish B/My HAL from CD19(+)-AML; CD19 didn't express on normal myeloid cells but did on some AML cells. Therefore it can be used to detect the minimal residual disease.

Immunophenotypic Features of Adult CD+2 B Cell Acute Lymphoblastic Leukemia

Comparative Analysis of Previously Untreated Adult and Childhood CD2+ Associated B Cell Acute Lymphoblastic Leukemia

High Expression Of Musashi-2 Indicates Poor Prognosis In Adult B-Cell Acute Lymphoblastic Leukemia

Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry]

Immunophenotypic Features of Adult B-lymphoblastic Leukemia

[The Expression of CD19 in 210 Cases of Childhood Acute Leukemia and Its Significance].

Immunophenotyping characteristics of adult patients with acute lymphoblastic leukemia in different ages]

[Characteristics of 4 specific target antigens in adult acute lymphoblastic leukemia]

Expression of CD20 in adult B-lineage acute lymphoblastic leukemia and its clinical significance

Comparison Between CD19 and CD20 Expression Patterns on Acute Leukemic Cells.

Development-associated Immunophenotypes Reveal the Heterogeneous and Individualized Early Responses of Adult B-acute Lymphoblastic Leukemia

Immunophenotypic analysis of Philadelphia chromosome positive acute lymphoblastic leukaemia in adults]

Analysis of immunophenotype of children acute lymphoblastlc leukemia

Immunophenotype Analysis of 85 Cases Childhood Acute Lymhoblastic Leukemia

[Probe of Classification of Adult Acute Lymphoblastic Leukemia].

[Expression of Two Subtype Molecules of CD133 in Childhood with B Linage Acute Lymphoblastic Leukemia and Its Clinical Significance].

[Clinical Significance of CD34(+)CD38(+) and CD34(+)CD38(low/-) Subgroups in Bone Marrow of Patients with B Lymphoblastic Leukemia].

[Immunophenotype of Acute Leukemia and Its Clinical Significance].

Analysis on the immunophenotype of acute leukemia and its clinical significance in children

CDX2 gene expression and clinical significance in children with acute lymphoblastic leukemia

Immunophenotype and Increased Presence of CD4(+)CD25(+) Regulatory T Cells in Patients with Acute Lymphoblastic Leukemia.